CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,106,000 | -29.3% | 340,320 | 0.0% | 0.05% | -35.6% |
| Q2 2017 | $1,565,000 | +22.6% | 340,320 | 0.0% | 0.07% | +21.7% |
| Q1 2017 | $1,276,000 | +33.9% | 340,320 | 0.0% | 0.06% | +11.1% |
| Q4 2016 | $953,000 | -98.6% | 340,320 | -88.0% | 0.05% | -98.6% |
| Q3 2016 | $68,836,000 | +49.8% | 2,844,483 | +2.0% | 4.00% | +15.2% |
| Q2 2016 | $45,967,000 | +115.8% | 2,787,542 | +129.3% | 3.47% | +110.0% |
| Q1 2016 | $21,301,000 | -41.8% | 1,215,833 | +3.4% | 1.65% | -18.9% |
| Q4 2015 | $36,601,000 | – | 1,175,733 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |